Related Experiment Videos
Pneumatic balloon dilation for esophageal achalasia
1Gastroenterology Service, Department of Medicine, Brooke Army Medical Center, San Antonio, Texas 78234, USA.
Gastrointestinal Endoscopy Clinics of North America
|April 25, 2001
Summary
Pneumatic balloon dilation is the preferred treatment for achalasia, offering 80-85% long-term success. Experienced endoscopists using a graded approach minimize complications for this effective therapy.
Area of Science:
- Gastroenterology
- Endoscopic Therapeutics
Background:
- Achalasia management relies on pneumatic balloon dilation as the primary medical intervention.
- Pneumatic dilation demonstrates superior efficacy compared to other non-surgical treatments like botulinum toxin injections.
Purpose of the Study:
- To evaluate the efficacy and safety of pneumatic balloon dilation for achalasia.
- To outline best practices for performing pneumatic dilation to maximize patient outcomes.
Main Methods:
- Utilizing a graded balloon dilation technique, starting with a 3.0-cm Rigiflex balloon and progressing to 3.5-cm and 4.0-cm if needed.
- Emphasis on endoscopist experience and standardized protocols to mitigate risks.
Main Results:
- Achieves an 80-85% rate of excellent or good long-term results.
- The graded Rigiflex balloon approach is identified as the safest method.
- Complication rates are approximately 3% for Rigiflex and 6% for Witzel dilation.
- While some patients develop GER, most remain asymptomatic.
Conclusions:
- Pneumatic balloon dilation is a highly effective and safe treatment for achalasia when performed by experienced endoscopists.
- A graded dilation protocol is recommended for optimal safety and efficacy.
- Surgery should be considered for patients unresponsive to three dilation sessions, though repeat dilations are an alternative.